Skip to main content
. Author manuscript; available in PMC: 2021 Oct 21.
Published in final edited form as: Nat Med. 2020 Oct 26;26(12):1852–1858. doi: 10.1038/s41591-020-1089-8

Fig. 2 ∣. Comutation oncoprint of eligible Beat AML trial patients.

Fig. 2 ∣

Genes with genomic alterations (short variants and insertions/deletions) are listed in descending order of frequency and each column represents an individual patient. Red indicates that the alteration was present at an allele frequency of ≥30% and blue <30%.